Preoperative chemotherapy for lung cancer does not increase surgical morbidity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Preoperative chemotherapy for lung cancer does not increase surgical morbidity

Published:2001-04 Issue:4 Volume:71 Page:1105-1112
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Siegenthaler Michael P,Pisters Katherine M,Merriman Kelly W,Roth Jack A,Swisher Stephen G,Walsh Garrett L,Vaporciyan Ara A,Smythe W.Roy,Putnam Joe B

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference27 articles.

1. Cancer statistics, 1999;Landis;CA Cancer J Clin,1999

2. Survival in early-stage non–small cell lung cancer;Nesbitt;Ann Thorac Surg,1995

3. Revisions in the international system for staging lung cancer;Mountain;Chest,1997

4. Randomized trial comparing postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation with irradiation alone in stage III (N2) non–small cell lung cancer;Pisters;J Surg Oncol,1994

5. A phase 3 randomized trial of immediate combination chemotherapy vs delayed combination chemotherapy in patients with completely resected stage II and III non–small cell carcinoma of the lung;Figlin;Chest,1994

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preoperative chemotherapy on cutaneous wound healing in lung cancer patients: A meta‐analysis;International Wound Journal;2023-12-20

2. Postoperative hypoxaemic acute respiratory failure after neoadjuvant treatment for lung cancer: radiologic findings and risk factors;European Journal of Cardio-Thoracic Surgery;2022-12-02

3. Management of Complications After Lung Resection;Thoracic Surgery Clinics;2020-08

4. Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy;Clinical Lung Cancer;2020-07

5. Is Resection of Persistent N2 Disease After Induction Therapy Effective?;Difficult Decisions in Surgery: An Evidence-Based Approach;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3